NCT00001650View on ClinicalTrials.gov

Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients

CompletedOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

September 19, 1997

Study Completion Date

May 13, 2011

Conditions
HIV InfectionAcquired Immunodeficiency Syndrome
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001650 - Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients | Biotech Hunter | Biotech Hunter